For a 28-year-old biotech entrepreneur, Frenchman Xavier Duportet has a standout resume: a PhD in biology and genome engineering from MIT, a lab at Paris’s Louis Pasteur Institute, and award-winning research with his name on it. Still, in Paris, as in capitals across Europe, it’s much harder for him to raise money than for most of his tech peers.